Neupro (Rotigotine) Transdermal System: A Comprehensive Overview Neupro is a prescription medication delivered via a transdermal patch, primarily used in the treatment of Parkinson’s disease and moderate-to-severe primary restless leg …
Tag:
Certificates
-
-
Ares Commercial Real Estate: Navigating a Transition in Commercial Real Estate Financing Ares Commercial Real Estate Corporation (ACRE) is currently facing a period of heightened investor scrutiny as the commercial …
-
Suntex Enterprises to Acquire Deep South Electrical and GoldenEra Development AUSTIN, Texas – March 5, 2026 – Suntex Enterprises, Inc. (OTC: SNTX) announced today that it has executed a Letter …
-
HYTN Innovations Extends Marketing Program with MCS Market Communication Service GmbH VANCOUVER, British Columbia – March 2, 2026 – HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN”), …
-
Understanding Open Finish Turbo Options on Spotify Technology Open End Turbo options offer investors a leveraged way to participate in the potential gains – and risks – associated with Spotify …
-
Humanoid Global Invests in HowToRobot to Accelerate Automation Solutions Humanoid Global Holdings Corp. Has completed a strategic investment in HOWTOROBOT HOLDING INC. (“HowToRobot”), a global marketplace for robotics solutions, and …
-
United Airlines Restructures MileagePlus Loyalty Program Amidst FAA Scrutiny and Rising Fuel Costs United Airlines is currently facing a complex set of challenges, including a restructuring of its MileagePlus loyalty …
-
LAS VEGAS, Feb. 12, 2026 (GLOBE NEWSWIRE) — Planet 13 Holdings Inc. (CSE: PLTH) (OTCQX: PLNH) (“Planet 13” or the “Company”), a leading vertically-integrated multi-state cannabis company, today announced the …
-
Humanoid shares are moving in early 2026 in an environment of profound technological changes in the robotics industry. There is currently no concrete company news. Investors are therefore focusing on …
-
AUSTIN, TX and DURHAM, NC, Feb. 06, 2026 (GLOBE NEWSWIRE) — Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of novel therapeutics targeting tumor necrosis …